Rheumatoid arthritis: CCN1, a novel RA target?
Rheumatoid arthritis: CCN1, a novel RA target?
复制标题
DOI:
10.1038/nrrheum.2016.138
复制
发表时间:
2016-10-01
期刊:
影响因子:
--
通讯作者:
Barranco, Caroline
中科院分区:
文献类型:
--
作者:
Barranco, Caroline
Protein CYR61 (cysteine-rich angiogenic inducer 61, also known as CCN1) is an important proinflammatory cytokine in rheumatoid arthritis (RA), according to new evidence published by Taiwanese researchers. They found elevated levels of CCN1 in synovial fluid from patients with RA, and showed that in mice with collagen-induced arthritis, a model of RA, knockdown of CCN1 (using a short hairpin RNA delivered by a lentiviral vector) suppressed joint swelling and cartilage erosion.Interestingly, knockdown of CCN1 also blocked the production of vascular endothelial growth factor (VEGF) by osteoblasts, leading to suppression of pannus neovascularization and decreased expression of angiogenesis markers.“Our work also demonstrates a link between osteoblasts and angiogenesis in RA,” highlights Chih-Hsin Tang, corresponding author of the study.“We provide evidence showing that osteoblasts produce VEGF and promote endothelial progenitor cell (EPC) infiltration and angiogenesis in the joint microenvironment during RA,” he explains.